Terms: = Pancreatic cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
31 results:
1. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.
Zheng X; Lin J; Xiong J; Guan Y; Lan B; Li Y; Gao X; Fei Z; Chen L; Chen L; Chen L; Chen G; Guo Z; Yi X; Cao W; Ai X; Zhou C; Li X; Zhao J; Yan X; Yu Q; Si L; Chen Y; Chen C
BMC Cancer; 2023 Jul; 23(1):686. PubMed ID: 37479966
[TBL] [Abstract] [Full Text] [Related]
2. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
3. Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant pancreatic cancer.
Goodwin CM; Waters AM; Klomp JE; Javaid S; Bryant KL; Stalnecker CA; Drizyte-Miller K; Papke B; Yang R; Amparo AM; Ozkan-Dagliyan I; Baldelli E; Calvert V; Pierobon M; Sorrentino JA; Beelen AP; Bublitz N; Lüthen M; Wood KC; Petricoin EF; Sers C; McRee AJ; Cox AD; Der CJ
Cancer Res; 2023 Jan; 83(1):141-157. PubMed ID: 36346366
[TBL] [Abstract] [Full Text] [Related]
4. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
Tong H; Liu X; Peng C; Shen B; Zhu Z
Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.
Dang F; Nie L; Zhou J; Shimizu K; Chu C; Wu Z; Fassl A; Ke S; Wang Y; Zhang J; Zhang T; Tu Z; Inuzuka H; Sicinski P; Bass AJ; Wei W
Nat Commun; 2021 Sep; 12(1):5386. PubMed ID: 34508104
[TBL] [Abstract] [Full Text] [Related]
6. Kaempferol suppresses proliferation and induces apoptosis and DNA damage in human gallbladder cancer cells through the CDK4/cdk6/cyclin D1 pathway.
Liu ZQ; Yao GL; Zhai JM; Hu DW; Fan YG
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1311-1321. PubMed ID: 33629301
[TBL] [Abstract] [Full Text] [Related]
7. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Panzeri V; Manni I; Capone A; Naro C; Sacconi A; Di Agostino S; de Latouliere L; Montori A; Pilozzi E; Piaggio G; Capurso G; Sette C
Mol Oncol; 2021 Feb; 15(2):579-595. PubMed ID: 33159833
[TBL] [Abstract] [Full Text] [Related]
8. CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in pancreatic Adenocarcinoma.
Salvador-Barbero B; Álvarez-Fernández M; Zapatero-Solana E; El Bakkali A; Menéndez MDC; López-Casas PP; Di Domenico T; Xie T; VanArsdale T; Shields DJ; Hidalgo M; Malumbres M
Cancer Cell; 2020 Mar; 37(3):340-353.e6. PubMed ID: 32109375
[TBL] [Abstract] [Full Text] [Related]
9. Abemaciclib Is Effective Against pancreatic cancer Cells and Synergizes with HuR and YAP1 Inhibition.
Dhir T; Schultz CW; Jain A; Brown SZ; Haber A; Goetz A; Xi C; Su GH; Xu L; Posey J; Jiang W; Yeo CJ; Golan T; Pishvaian MJ; Brody JR
Mol Cancer Res; 2019 Oct; 17(10):2029-2041. PubMed ID: 31383722
[TBL] [Abstract] [Full Text] [Related]
10. Real-Time Targeted Genome Profile Analysis of pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Singhi AD; George B; Greenbowe JR; Chung J; Suh J; Maitra A; Klempner SJ; Hendifar A; Milind JM; Golan T; Brand RE; Zureikat AH; Roy S; Schrock AB; Miller VA; Ross JS; Ali SM; Bahary N
Gastroenterology; 2019 Jun; 156(8):2242-2253.e4. PubMed ID: 30836094
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract] [Full Text] [Related]
12. Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.
Keutgen XM; Kumar S; Gara SK; Boufraqech M; Agarwal S; Hruban RH; Nilubol N; Quezado M; Finney R; Cam M; Kebebew E
Cancer; 2018 Feb; 124(3):636-647. PubMed ID: 29149451
[TBL] [Abstract] [Full Text] [Related]
13. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
[TBL] [Abstract] [Full Text] [Related]
14. Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma.
Wu C; Ruan T; Liu W; Zhu X; Pan J; Lu W; Yan C; Tao K; Zhang W; Zhang C
Curr Pharm Des; 2018; 24(5):564-575. PubMed ID: 28322158
[TBL] [Abstract] [Full Text] [Related]
15. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro.
Fahrioğlu U; Dodurga Y; Elmas L; Seçme M
Gene; 2016 Jan; 576(1 Pt 3):476-82. PubMed ID: 26516023
[TBL] [Abstract] [Full Text] [Related]
16. CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells.
Wang H; Qian Z; Zhao H; Zhang X; Che S; Zhang H; Shang H; Bao J; Hao C; Liu J; Li Z
Mol Med Rep; 2015 Sep; 12(3):3902-3908. PubMed ID: 26035694
[TBL] [Abstract] [Full Text] [Related]
17. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract] [Full Text] [Related]
18. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Shankar S; Srivastava RK
PLoS One; 2014; 9(4):e92161. PubMed ID: 24694877
[TBL] [Abstract] [Full Text] [Related]
19. Embelin suppresses pancreatic cancer growth by modulating tumor immune microenvironment.
Marsh JL; Jackman CP; Tang SN; Shankar S; Srivastava RK
Front Biosci (Landmark Ed); 2014 Jan; 19(1):113-25. PubMed ID: 24389175
[TBL] [Abstract] [Full Text] [Related]
20. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
[TBL] [Abstract] [Full Text] [Related]
[Next]